Detalhe da pesquisa
1.
A MultiCenter, OpenLabel, SingleArm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
J Clin Immunol
; 42(3): 500-511, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34973143
2.
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
J Clin Immunol
; 42(3): 512-513, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35174440